Duke Children's Hospital
Duke Children's Hospital
Durham, North Carolina, United States5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Postoperative and Chronic Pain Genetic Spine and Pectus Surgery Study | Bone Diseases, Developmental, Chronic Pain, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Kyphosis, Musculoskeletal Abnormalities, Neurologic Manifestations, Pain, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Pain, Signs and Symptoms, Spinal Curvatures, bone disorder, musculoskeletal system disorder, pectus excavatum, scoliosis, vertebral column disorder | Active, not recruiting | Not stated | 2026-10-08 | NCT02998138 | |
| PROSpect: Prone and Oscillation Pediatric Clinical Trial | Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Active, not recruiting | Not applicable | 2026-05-05 | NCT03896763 | |
| ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adamantinous craniopharyngioma, craniopharyngioma, neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 2 | 2026-04-23 | NCT05233397 | |
| Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure | Digestive System Diseases, Hyperphagia, Intestinal Failure, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Signs and Symptoms, Signs and Symptoms, Digestive, digestive system disorder, intestinal disorder, malabsorption syndrome, short bowel syndrome | Recruiting | Not stated | 2026-03-23 | NCT04629014 | |
| Evolutionary Therapy for Rhabdomyosarcoma | Myosarcoma, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, myomatous neoplasm, neoplasm, rhabdomyosarcoma, sarcoma | Active, not recruiting | Phase 2 | 2025-11-26 | NCT04388839 |